Our previous study demonstrated that I-PostC may protect against LIR-induced AKI by inhibiting the Toll-like receptor 4 (TLR4)/NF‐κB signaling pathway and reducing the expression of proinflammatory cytokines [20]. Here, TLR4 is linked to acute kidney injury.